These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36540019)

  • 41. S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patients.
    Deckers EA; Wevers KP; Muller Kobold AC; Damude S; Vrielink OM; van Ginkel RJ; Been LB; van Leeuwen BL; Hoekstra HJ; Kruijff S
    J Surg Oncol; 2019 Nov; 120(6):1031-1037. PubMed ID: 31468535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review.
    Rajagopal S; Yao X; Abadir W; Baetz TD; Easson A; Knight G; McWhirter E; Nessim C; Rosen CF; Sun A; Wright FC; Petrella TM
    Surg Oncol; 2024 Jun; 54():102077. PubMed ID: 38657486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of lymph node ultrasound and whole body
    Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
    Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
    Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
    Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance after surgical treatment of melanoma: futility of routine chest radiography.
    Brown RE; Stromberg AJ; Hagendoorn LJ; Hulsewede DY; Ross MI; Noyes RD; Goydos JS; Urist MM; Edwards MJ; Scoggins CR; McMasters KM; Martin RC
    Surgery; 2010 Oct; 148(4):711-6; discussion 716-7. PubMed ID: 20800862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma.
    Dieng M; Turner RM; Lord SJ; Einstein AJ; Menzies AM; Saw RPM; Nieweg OE; Thompson JF; Morton RL
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
    Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
    Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Lawal I; Lengana T; Ololade K; Boshomane T; Reyneke F; Modiselle M; Vorster M; Sathekge M
    Nuklearmedizin; 2017 Jun; 56(3):83-89. PubMed ID: 28154879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma.
    Hayes AJ; Moskovic E; O'Meara K; Smith HG; Pope RJE; Larkin J; Thomas JM
    Br J Surg; 2019 May; 106(6):729-734. PubMed ID: 30816996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway.
    Winge-Main A; Robsahm TE; Nyakas M; Festervoll G; Torkilseng E; Thybo S; Pati S; Carroll R
    Future Oncol; 2023 Jan; 19(3):205-215. PubMed ID: 36974621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphatic mapping and sentinel lymph node biopsy in the management of primary cutaneous melanoma: report of a single-centre experience.
    Cecchi R; De Gaudio C; Buralli L; Innocenti S
    Tumori; 2006; 92(2):113-7. PubMed ID: 16724689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Kwak JJ; Kesner AL; Gleisner A; Jensen A; Friedman C; McCarter MD; Koo PJ; Morgan RL; Kounalakis N
    Ann Surg Oncol; 2020 May; 27(5):1432-1438. PubMed ID: 31773513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study.
    Kaumanns A; König D; Hojski A; Cattaneo M; Chirindel A; Wiese M; Tamm M; Lardinois D; Rothschild SI
    Lung Cancer; 2022 Nov; 173():14-20. PubMed ID: 36108578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
    Twycross SH; Burger H; Holness J
    S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and Prognostic Value of
    Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
    Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.
    Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C
    J Clin Oncol; 2020 Nov; 38(33):3925-3936. PubMed ID: 32946353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.